Veradermics shares surge as hair loss drug trial meets primary endpoint
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
In phase 2/3 clinical trials targeting male pattern baldness, the oral sustained-release minoxidil preparation VDPHL01 achieved all primary and key secondary endpoints with extremely high statistical significance. Read more
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Kaspa Jumps 5% as KaChat 4.0 “Everywhere Update” Rolls Out
BeInCrypto•2026/08/27 23:15
Ahead of Fed Meeting, Former Governor Miran Says Rate Hike Would Be ‘Weird'
BeInCrypto•2026/08/27 23:15
Crypto prices
More
Bitcoin
BTC
$80,171.55
+1.85%
Ethereum
ETH
$2,511.36
+0.84%
Tether USDt
USDT
$1
+0.00%
BNB
BNB
$712.17
+1.07%
XRP
XRP
$1.45
+3.67%
USDC
USDC
$0.9999
-0.01%
Solana
SOL
$109.01
+8.82%
TRON
TRX
$0.3375
+0.52%
Hyperliquid
HYPE
$84.92
+4.12%
Dogecoin
DOGE
$0.08899
+2.87%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now